Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients.
The classification of Blood Irradiation includes X-ray blood irradiation and Gamma-ray blood irradiation. And the proportion of X-ray blood irradiation in 2017 is about 52, and the proportion is in increasing trend from 2013 to 2017.
Blood Irradiation is widely used in blood bank, hospital and research institutions. The most proportion of blood irradiation is used in blood bank, and the proportion in 2017 is about 74.62%.
North America is the largest sales place, with a Sales market share nearly 44% in 2017. Following North America, Asia-Pacific is the second largest sales place with the Sales market share of 26%.
The global Blood Irradiation market is valued at 44 million US$ in 2018 and will reach 63 million US$ by the end of 2025, growing at a CAGR of 4.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Blood Irradiation market based on company, product type, end user and key regions.

This report studies the global market size of Blood Irradiation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Blood Irradiation in these regions.
This research report categorizes the global Blood Irradiation market by top players/brands, region, type and end user. This report also studies the global Blood Irradiation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Wuhan HNC Technology Co., Ltd.
Wenzhou Gengsheng Health Medical Equipment Co., Ltd.
O3Vets
STS Steuerungstechnik + Strahlenchutz GmbH
Best Theratronics
Hitaci
Gilardoni
Gamma-Service
Cegelec
Rad Source
JL SHEPHERD & ASSOCIATES
Shinva Medical
NPIC
CIF medical

Market size by Product
X-ray Blood Irradiation
Gamma-ray Blood Irradiation
Market size by End User
Blood Bank
Hospital
Research Institutions

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Blood Irradiation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Blood Irradiation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Blood Irradiation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Blood Irradiation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Blood Irradiation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Blood Irradiation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.